The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 18, 2018

Filed:

Dec. 18, 2014
Applicant:

Iomet Pharma Ltd., Edinburgh, Midlothian, GB;

Inventors:

Bill Hunter, Dundee, GB;

Stuart McElroy, Dundee, GB;

Alan Wise, Edinburgh, GB;

Assignee:

Iomet Pharma Ltd., Midlothian, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/26 (2006.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/26 (2013.01); C12Q 1/48 (2013.01); G01N 2333/90241 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract

Provided is a high-throughput coupled enzyme method of screening for a tryptophan-2,3-dioxygenase (TDO) inhibitor compound and/or an indoleamine-2,3-dioxygenase (IDO) inhibitor compound, which method comprises: (a) reacting tryptophan with isolated IDO and/or isolated TDO in the presence of a test compound to form N-formylkynurenine; (b) reacting N-formylkynurenine from step (a) with isolated kynurenine formamidase to form kynurenine; and (c) detecting the kynurenine produced in step (b) and determining whether the test compound is a TDO and/or an IDO inhibitor compound or not from the presence or absence or quantity of the detected kynurenine, wherein step (a) is conducted in the presence of a reducing system suitable for converting IDO and/or TDO from the Feto the Festate, and which does not prevent the formation of kynurenine in step (c).


Find Patent Forward Citations

Loading…